Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 796104-87-5
2. 391rt5q293
3. Ncgc00181349-01
4. 3-thiopheneacetic Acid, 5-(bis(carboxymethyl)amino)-2-carboxy-4-cyano-, Strontium Salt, Hydrate (1:2:7)
5. Distrontium;5-[bis(carboxylatomethyl)amino]-3-(carboxylatomethyl)-4-cyanothiophene-2-carboxylate;heptahydrate
6. 135459-87-9
7. Unii-391rt5q293
8. Dsstox_cid_26918
9. Dsstox_rid_82014
10. Dsstox_gsid_46918
11. Chembl3182450
12. Dtxsid7046918
13. Tox21_112807
14. Ac-748
15. Mfcd12031997
16. Akos015964936
17. Ncgc00181349-02
18. Cas-796104-87-5
19. Ft-0688439
20. Q27256841
| Molecular Weight | 639.6 g/mol |
|---|---|
| Molecular Formula | C12H20N2O15SSr2 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 4 |
| Exact Mass | 639.8696636 g/mol |
| Monoisotopic Mass | 639.8696636 g/mol |
| Topological Polar Surface Area | 223 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 533 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 10 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
97
PharmaCompass offers a list of Strontium Ranelate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Strontium Ranelate manufacturer or Strontium Ranelate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Strontium Ranelate manufacturer or Strontium Ranelate supplier.
PharmaCompass also assists you with knowing the Strontium Ranelate API Price utilized in the formulation of products. Strontium Ranelate API Price is not always fixed or binding as the Strontium Ranelate Price is obtained through a variety of data sources. The Strontium Ranelate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Strontium Ranelate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Strontium Ranelate, including repackagers and relabelers. The FDA regulates Strontium Ranelate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Strontium Ranelate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Strontium Ranelate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Strontium Ranelate supplier is an individual or a company that provides Strontium Ranelate active pharmaceutical ingredient (API) or Strontium Ranelate finished formulations upon request. The Strontium Ranelate suppliers may include Strontium Ranelate API manufacturers, exporters, distributors and traders.
click here to find a list of Strontium Ranelate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Strontium Ranelate written confirmation (Strontium Ranelate WC) is an official document issued by a regulatory agency to a Strontium Ranelate manufacturer, verifying that the manufacturing facility of a Strontium Ranelate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Strontium Ranelate APIs or Strontium Ranelate finished pharmaceutical products to another nation, regulatory agencies frequently require a Strontium Ranelate WC (written confirmation) as part of the regulatory process.
click here to find a list of Strontium Ranelate suppliers with Written Confirmation (WC) on PharmaCompass.
Strontium Ranelate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Strontium Ranelate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Strontium Ranelate GMP manufacturer or Strontium Ranelate GMP API supplier for your needs.
A Strontium Ranelate CoA (Certificate of Analysis) is a formal document that attests to Strontium Ranelate's compliance with Strontium Ranelate specifications and serves as a tool for batch-level quality control.
Strontium Ranelate CoA mostly includes findings from lab analyses of a specific batch. For each Strontium Ranelate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Strontium Ranelate may be tested according to a variety of international standards, such as European Pharmacopoeia (Strontium Ranelate EP), Strontium Ranelate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Strontium Ranelate USP).
